1
/
of
0
FDA Recall Reports for Cubicin 500 mg IV – RES #88867/D-0093-2022
FDA Recall Reports for Cubicin 500 mg IV – RES #88867/D-0093-2022
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Copies of recall reports for RES #88867 for Cubicin (daptomycin for injection) 500 mg IV, Lot 934778, expiring June 2022; recalling firm Merck Sharp & Dohme Corp; recall number D-0093-2022; NDC: 67919-011-01; trace lot origins
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details